Contact
Please use this form to send email to PR contact of this press release:
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
TO:
Please use this form to send email to PR contact of this press release:
Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
TO: